Liver Toxicity of Current Antiretroviral Regimens in HIV-Infected Patients with Chronic Viral Hepatitis in a Real-Life Setting: The HEPAVIR SEG-HEP Cohort.

about

Liver Toxicity of Current Antiretroviral Regimens in HIV-Infected Patients with Chronic Viral Hepatitis in a Real-Life Setting: The HEPAVIR SEG-HEP Cohort.

Item

http://www.wikidata.org/entity/Q35915593

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Liver Toxicity of Current Anti ...... g: The HEPAVIR SEG-HEP Cohort.

@ast

Liver Toxicity of Current Anti ...... g: The HEPAVIR SEG-HEP Cohort.

@en

type

Item

label

Liver Toxicity of Current Anti ...... g: The HEPAVIR SEG-HEP Cohort.

@ast

Liver Toxicity of Current Anti ...... g: The HEPAVIR SEG-HEP Cohort.

@en

prefLabel

Liver Toxicity of Current Anti ...... g: The HEPAVIR SEG-HEP Cohort.

@ast

Liver Toxicity of Current Anti ...... g: The HEPAVIR SEG-HEP Cohort.

@en

P1476

Liver Toxicity of Current Anti ...... g: The HEPAVIR SEG-HEP Cohort.

@en

P2093

Antonio Collado

http://www.w3.org/2001/XMLSchema#string

Dolores Merino

http://www.w3.org/2001/XMLSchema#string

HEPAVIR SEG-HEP-2007 Study Gro ...... nfermedades Infecciosas (SAEI)

http://www.w3.org/2001/XMLSchema#string

Inés Pérez-Camacho

http://www.w3.org/2001/XMLSchema#string

Josefa Ruiz-Morales

http://www.w3.org/2001/XMLSchema#string

José A Mira

http://www.w3.org/2001/XMLSchema#string

María Carmen Gálvez-Contreras

http://www.w3.org/2001/XMLSchema#string

María José Ríos

http://www.w3.org/2001/XMLSchema#string

Patricia Monje-Agudo

http://www.w3.org/2001/XMLSchema#string

P2860

Liver enzyme elevation during darunavir-based antiretroviral treatment in HIV-1-infected patients with or without hepatitis C coinfection: data from the ICONA foundation cohort.

Hepatic safety and tolerability of raltegravir among HIV patients coinfected with hepatitis B and/or C

Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority trial.

Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection.

Incidence of liver injury after beginning antiretroviral therapy with efavirenz or nevirapine.

Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial.

Clinical significance of hyperbilirubinemia among HIV-1-infected patients treated with atazanavir/ritonavir through 96 weeks in the CASTLE study

Atazanavir and other determinants of hyperbilirubinemia in a cohort of 1150 HIV-positive patients: results from 9 years of follow-up

Risk of Liver Enzyme Elevation During Treatment With Ritonavir-Boosted Protease Inhibitors Among HIV-Monoinfected and HIV/HCV-Coinfected Patients.

Safety profile of maraviroc in patients coinfected with HIV-1 and hepatitis B or C included in the maraviroc expanded access program.

P304

e0148104

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0148104

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Karin Neukam

Juan A. Pineda

Francisco Téllez

Antonio Rivero-Juarez

A Rivero

P577

2016-02-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

293168811

http://www.w3.org/2001/XMLSchema#string

P698

26848975

http://www.w3.org/2001/XMLSchema#string

P932

4743911

http://www.w3.org/2001/XMLSchema#string